{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:31:09Z","timestamp":1793370669296,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T00:00:00Z","timestamp":1476403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10147-016-1036-3","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T05:48:13Z","timestamp":1476424093000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-5047","authenticated-orcid":false,"given":"Amit","family":"Odelia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joffe","family":"Erel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Chava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herishanu","family":"Yair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarid","family":"Nadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishner","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivi","family":"Irit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,14]]},"reference":[{"issue":"4","key":"1036_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","volume":"7","author":"NA Pavlidis","year":"2002","unstructured":"Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279\u2013287","journal-title":"Oncologist"},{"issue":"9815","key":"1036_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(11)61348-2","volume":"379","author":"B Brenner","year":"2012","unstructured":"Brenner B, Avivi I, Lishner M (2012) Haematological cancers in pregnancy. Lancet 379(9815):580\u2013587. doi: 10.1016\/S0140-6736(11)61348-2","journal-title":"Lancet"},{"issue":"1","key":"1036_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejogrb.2012.10.026","volume":"167","author":"SN Han","year":"2013","unstructured":"Han SN, Kesic VI, Van Calsteren K et al (2013) Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol 167(1):18\u201323. doi: 10.1016\/j.ejogrb.2012.10.026","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"1036_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JCO.2015.62.4445","volume":"34","author":"M Lishner","year":"2016","unstructured":"Lishner M, Avivi I, Apperley JF et al (2016) Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol 34(5):501\u2013508. doi: 10.1200\/JCO.2015.62.4445","journal-title":"J Clin Oncol"},{"issue":"5","key":"1036_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.blre.2014.06.004","volume":"28","author":"I Avivi","year":"2014","unstructured":"Avivi I, Farbstein D, Brenner B et al (2014) Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. Blood Rev 28(5):213\u2013220. doi: 10.1016\/j.blre.2014.06.004","journal-title":"Blood Rev"},{"key":"1036_CR6","unstructured":"NCCNclinical practice guidelines in oncology (2013) Non-Hodgkin\u2019s Lymphomas. Version 1. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf . Accessed 13 Novemb 2014"},{"issue":"5","key":"1036_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1470-2045(05)70169-8","volume":"6","author":"HB Kal","year":"2005","unstructured":"Kal HB, Struikmans H (2005) Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6(5):328\u2013333. doi: 10.1016\/S1470-2045(05)70169-8","journal-title":"Lancet Oncol"},{"issue":"5","key":"1036_CR8","first-page":"347","volume":"16","author":"RL Brent","year":"1989","unstructured":"Brent RL (1989) The effect of embryonic and fetal exposure to X-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 16(5):347\u2013368","journal-title":"Semin Oncol"},{"issue":"4","key":"1036_CR9","doi-asserted-by":"publisher","first-page":"W737","DOI":"10.2214\/AJR.10.6351","volume":"197","author":"LM Austin","year":"2011","unstructured":"Austin LM, Frush DP (2011) Compendium of national guidelines for imaging the pregnant patient. Am J Roentgenol 197(4):W737\u2013W746. doi: 10.2214\/AJR.10.6351","journal-title":"Am J Roentgenol"},{"issue":"5","key":"1036_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/j.semperi.2013.06.005","volume":"37","author":"D Bulas","year":"2013","unstructured":"Bulas D, Egloff A (2013) Benefits and risks of MRI in pregnancy. Semin Perinatol 37(5):301\u2013304. doi: 10.1053\/j.semperi.2013.06.005","journal-title":"Semin Perinatol"},{"issue":"2","key":"1036_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1148\/radiol.10100652","volume":"258","author":"MR M\u00fchler","year":"2011","unstructured":"M\u00fchler MR, Cl\u00e9ment O, Salomon LJ et al (2011) Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. Radiology 258(2):455\u2013460. doi: 10.1148\/radiol.10100652","journal-title":"Radiology"},{"issue":"2","key":"1036_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ctrv.2009.11.004","volume":"36","author":"HA Azim","year":"2010","unstructured":"Azim HA, Pavlidis N, Peccatori FA (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat Rev 36(2):110\u2013121. doi: 10.1016\/j.ctrv.2009.11.004","journal-title":"Cancer Treat Rev"},{"issue":"32","key":"1036_CR13","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1200\/JCO.2013.49.8220","volume":"31","author":"AM Evens","year":"2013","unstructured":"Evens AM, Advani R, Press OW et al (2013) Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol 31(32):4132\u20134139. doi: 10.1200\/JCO.2013.49.8220","journal-title":"J Clin Oncol"},{"key":"1036_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/asheducation-2008.1.33","volume":"2008","author":"V Bachanova","year":"2008","unstructured":"Bachanova V, Connors JM (2008) How is Hodgkin lymphoma in pregnancy best treated? ASH evidence-based review. Hematol Am Soc Hematol Educ Progr 2008:33\u201334. doi: 10.1182\/asheducation-2008.1.33","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"26","key":"1036_CR15","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1200\/JCO.2005.05.016","volume":"23","author":"JM Connors","year":"2005","unstructured":"Connors JM (2005) State-of-the-art therapeutics: Hodgkin\u2019s lymphoma. J Clin Oncol 23(26):6400\u20136408. doi: 10.1200\/JCO.2005.05.016","journal-title":"J Clin Oncol"},{"issue":"5","key":"1036_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","volume":"5","author":"E Cardonick","year":"2004","unstructured":"Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283\u2013291. doi: 10.1016\/S1470-2045(04)01466-4","journal-title":"Lancet Oncol"},{"issue":"3","key":"1036_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Avil\u00e9s","year":"2001","unstructured":"Avil\u00e9s A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2(3):173\u2013177","journal-title":"Clin Lymphoma"},{"issue":"6","key":"1036_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KME Hahn","year":"2006","unstructured":"Hahn KME, Johnson PH, Gordon N et al (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219\u20131226. doi: 10.1002\/cncr.22081","journal-title":"Cancer"},{"issue":"4","key":"1036_CR19","first-page":"278","volume":"2","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Amant F (2010) Chemotherapy during pregnancy: pharmacokinetics and -impact on foetal neurological development. Facts Views Vis ObGyn 2(4):278\u2013286","journal-title":"Facts Views Vis ObGyn"},{"issue":"3","key":"1036_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J et al (2010) Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 119(3):594\u2013600. doi: 10.1016\/j.ygyno.2010.08.019","journal-title":"Gynecol Oncol"},{"issue":"10","key":"1036_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3109\/00016349.2010.512070","volume":"89","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Ottevanger N et al (2010) Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 89(10):1338\u20131345. doi: 10.3109\/00016349.2010.512070","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"1036_CR22","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/annonc\/mdu140","volume":"25","author":"JGC van Hasselt","year":"2014","unstructured":"van Hasselt JGC, van Calsteren K, Heyns L et al (2014) Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol 25(10):2059\u20132065. doi: 10.1093\/annonc\/mdu140","journal-title":"Ann Oncol"},{"issue":"2","key":"1036_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.hoc.2011.01.001","volume":"25","author":"U Abadi","year":"2011","unstructured":"Abadi U, Koren G, Lishner M (2011) Leukemia and lymphoma in pregnancy. Hematol Oncol Clin N Am 25(2):277\u2013291. doi: 10.1016\/j.hoc.2011.01.001","journal-title":"Hematol Oncol Clin N Am"},{"issue":"4","key":"1036_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/GRF.0b013e318236e9f9","volume":"54","author":"M Brewer","year":"2011","unstructured":"Brewer M, Kueck A, Runowicz CD (2011) Chemotherapy in pregnancy. Clin Obstet Gynecol 54(4):602\u2013618. doi: 10.1097\/GRF.0b013e318236e9f9","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"1036_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1701-2163(15)30999-3","volume":"35","author":"G Koren","year":"2013","unstructured":"Koren G, Carey N, Gagnon R et al (2013) Cancer chemotherapy and pregnancy. J Obstet Gynaecol Cancer 35(3):263\u2013280","journal-title":"J Obstet Gynaecol Cancer"},{"issue":"2","key":"1036_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2005.10.014","volume":"42","author":"G Pentheroudakis","year":"2006","unstructured":"Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2):126\u2013140. doi: 10.1016\/j.ejca.2005.10.014","journal-title":"Eur J Cancer"},{"key":"1036_CR27","unstructured":"Koren G LMSS editors (2005) The Motherisk guide to cancer in pregnancy and lactation. 2nd ed, Motherisk Program, Toronto"},{"issue":"5","key":"1036_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1586\/14737140.4.5.889","volume":"4","author":"B Weisz","year":"2004","unstructured":"Weisz B, Meirow D, Schiff E et al (2004) Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther 4(5):889\u2013902. doi: 10.1586\/14737140.4.5.889","journal-title":"Expert Rev Anticancer Ther"},{"key":"1036_CR29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-61-108","volume":"61","author":"AI Rosenzweig","year":"1964","unstructured":"Rosenzweig AI, Crews QE, Hopwood HG (1964) Vinblastine sulfate in Hodgkin\u2019s disease in pregnancy. Ann Intern Med 61:108\u2013112","journal-title":"Ann Intern Med"},{"issue":"1","key":"1036_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1992.21","volume":"65","author":"M Lishner","year":"1992","unstructured":"Lishner M, Zemlickis D, Degendorfer P et al (1992) Maternal and foetal outcome following Hodgkin\u2019s disease in pregnancy. Br J Cancer 65(1):114\u2013117","journal-title":"Br J Cancer"},{"issue":"1","key":"1036_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bpobgyn.2011.10.007","volume":"26","author":"I El-Hemaidi","year":"2012","unstructured":"El-Hemaidi I, Robinson SE (2012) Management of haematological malignancy in pregnancy. Best Pract Res Clin Obstet Gynaecol 26(1):149\u2013160. doi: 10.1016\/j.bpobgyn.2011.10.007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"1036_CR32","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","volume":"117","author":"EF Chakravarty","year":"2011","unstructured":"Chakravarty EF, Murray ER, Kelman A et al (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood 117(5):1499\u20131506. doi: 10.1182\/blood-2010-07-295444","journal-title":"Blood"},{"issue":"8","key":"1036_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1470-2045(06)70797-5","volume":"7","author":"M Decker","year":"2006","unstructured":"Decker M, Rothermundt C, Holl\u00e4nder G et al (2006) Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 7(8):693\u2013694. doi: 10.1016\/S1470-2045(06)70797-5","journal-title":"Lancet Oncol"},{"issue":"3","key":"1036_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/COC.0b013e3181a44ca9","volume":"33","author":"E Cardonick","year":"2010","unstructured":"Cardonick E, Usmani A, Ghaffar S (2010) Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 33(3):221\u2013228. doi: 10.1097\/COC.0b013e3181a44ca9","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"1036_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","volume":"36","author":"A Avil\u00e9s","year":"1991","unstructured":"Avil\u00e9s A, D\u00edaz-Maqueo JC, Talavera A et al (1991) Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 36(4):243\u2013248","journal-title":"Am J Hematol"},{"issue":"4","key":"1036_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ctrv.2008.01.002","volume":"34","author":"D Pereg","year":"2008","unstructured":"Pereg D, Koren G, Lishner M (2008) Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 34(4):302\u2013312. doi: 10.1016\/j.ctrv.2008.01.002","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"1036_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/tera.1420170314","volume":"17","author":"J Warkany","year":"1978","unstructured":"Warkany J (1978) Aminopterin and methotrexate: folic acid deficiency. Teratology 17(3):353\u2013357. doi: 10.1002\/tera.1420170314","journal-title":"Teratology"},{"issue":"1","key":"1036_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H","volume":"60","author":"M Del Campo","year":"1999","unstructured":"Del Campo M, Kosaki K, Bennett FC et al (1999) Developmental delay in fetal aminopterin\/methotrexate syndrome. Teratology 60(1):10\u201312. doi: 10.1002\/(SICI)1096-9926(199907)60:1<10:AID-TERA5>3.0.CO;2-H","journal-title":"Teratology"},{"issue":"18","key":"1036_CR39","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","volume":"23","author":"AE Ring","year":"2005","unstructured":"Ring AE, Smith IE, Jones A et al (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23(18):4192\u20134197. doi: 10.1200\/JCO.2005.03.038","journal-title":"J Clin Oncol"},{"issue":"5","key":"1036_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.blre.2008.03.006","volume":"22","author":"T Shapira","year":"2008","unstructured":"Shapira T, Pereg D, Lishner M (2008) How I treat acute and chronic leukemia in pregnancy. Blood Rev 22(5):247\u2013259. doi: 10.1016\/j.blre.2008.03.006","journal-title":"Blood Rev"},{"issue":"7","key":"1036_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1182\/blood-2013-08-283580","volume":"123","author":"D Milojkovic","year":"2014","unstructured":"Milojkovic D, Apperley JF (2014) How I treat leukemia during pregnancy. Blood 123(7):974\u2013984. doi: 10.1182\/blood-2013-08-283580","journal-title":"Blood"},{"key":"1036_CR42","unstructured":"Wagner LK, American College of Radiology (2008) ACR practice guideline for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. Pract Guidel Tech Stand 2008 Reston, Am Coll Radiol"},{"issue":"3","key":"1036_CR43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8140(02)00329-8","volume":"66","author":"M Mazonakis","year":"2003","unstructured":"Mazonakis M, Varveris H, Fasoulaki M, Damilakis J (2003) Radiotherapy of Hodgkin\u2019s disease in early pregnancy: embryo dose measurements. Radiother Oncol 66(3):333\u2013339","journal-title":"Radiother Oncol"},{"issue":"6","key":"1036_CR44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.7326\/0003-4819-95-6-669","volume":"95","author":"C Jacobs","year":"1981","unstructured":"Jacobs C, Donaldson SS, Rosenberg SA et al (1981) Management of the pregnant patient with Hodgkin\u2019s disease. Ann Intern Med 95(6):669\u2013675","journal-title":"Ann Intern Med"},{"issue":"4","key":"1036_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683\u2013689. doi: 10.1200\/JCO.2009.23.2801","journal-title":"J Clin Oncol"},{"issue":"4","key":"1036_CR46","doi-asserted-by":"publisher","first-page":"367-e1","DOI":"10.1016\/j.ajog.2008.08.002","volume":"199","author":"JA Bastek","year":"2008","unstructured":"Bastek JA, Sammel MD, Par\u00e9 E et al (2008) Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol 199(4):367-e1. doi: 10.1016\/j.ajog.2008.08.002","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 5","key":"1036_CR47","doi-asserted-by":"publisher","first-page":"v266","DOI":"10.1093\/annonc\/mdq198","volume":"21","author":"G Pentheroudakis","year":"2010","unstructured":"Pentheroudakis G, Orecchia R, Hoekstra HJ et al (2010) Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v266\u2013v273. doi: 10.1093\/annonc\/mdq198","journal-title":"Ann Oncol"},{"issue":"5","key":"1036_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.siny.2007.05.004","volume":"12","author":"S Johnson","year":"2007","unstructured":"Johnson S (2007) Cognitive and behavioural outcomes following very preterm birth. Semin Fetal Neonatal Med 12(5):363\u2013373. doi: 10.1016\/j.siny.2007.05.004","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"1036_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/JCO.2015.63.3446","volume":"34","author":"CE Weibull","year":"2016","unstructured":"Weibull CE, Eloranta S, Smedby KE et al (2016) Pregnancy and the risk of relapse in patients diagnosed with hodgkin lymphoma. J Clin Oncol 34(4):337\u2013344. doi: 10.1200\/JCO.2015.63.3446","journal-title":"J Clin Oncol"},{"issue":"4","key":"1036_CR50","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.suronc.2011.06.002","volume":"20","author":"E Voulgaris","year":"2011","unstructured":"Voulgaris E, Pentheroudakis G, Pavlidis N (2011) Cancer and pregnancy: a comprehensive review. Surg Oncol 20(4):e175\u2013e185. doi: 10.1016\/j.suronc.2011.06.002","journal-title":"Surg Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1036-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T17:03:26Z","timestamp":1601139806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1036-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1036-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,14]]}}}